Xin Wang
Algemeen Directeur bij Genesis MedTech International Pte Ltd.
Vermogen: 113 100 $ op 31-05-2024
Profiel
Xin Wang is currently the Chairman & Chief Executive Officer at Jianshi Medical Technology (Shanghai) Co., Ltd., Genesis MedTech International Pte Ltd., and Boston Scientific International BV (China).
Previously, Mr. Wang served as the Senior Vice President & President-Asia Pacific at Boston Scientific Corp.
Mr. Wang also has a background in business, having obtained an undergraduate degree from the University of International Business & Economics and an MBA from The University of Chicago Booth School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2024 | 10 000 ( 0.50% ) | 113 100 $ | 31-05-2024 |
Actieve functies van Xin Wang
| Bedrijven | Functie | Begin |
|---|---|---|
Genesis MedTech International Pte Ltd.
 Genesis MedTech International Pte Ltd. Medical SpecialtiesHealth Technology Genesis MedTech International Pte Ltd. is a Singaporean medical device company that focuses on value segment multi-therapy medical device products for emerging markets. It has subsidiaries in Singapore, China, and Japan. The company was founded by a group of professionals and entrepreneurs with medtech experience and is headquartered in Singapore, Singapore. Xin Wang has been the CEO of the company since 2020. | Algemeen Directeur | 01-04-2020 |
| Boston Scientific International BV (China) | Corporate Officer/Principal | 25-06-2012 |
Jianshi Medical Technology (Shanghai) Co., Ltd.
 Jianshi Medical Technology (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Part of Genesis MedTech International Pte Ltd., Jianshi Medical Technology (Shanghai) Co., Ltd. is a Chinese company that manufactures and distributes medical devices. The company is based in Shanghai, China. The company was founded in 2019. The CEO is Xin Wang. | Algemeen Directeur | - |
Eerdere bekende functies van Xin Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| AIMFINITY INVESTMENT CORP. I | Directeur/Bestuurslid | 17-03-2023 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01-03-2020 |
Opleiding van Xin Wang
| University of International Business & Economics | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| AIMFINITY INVESTMENT CORP. I | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
| Boston Scientific International BV (China) | |
Jianshi Medical Technology (Shanghai) Co., Ltd.
Jianshi Medical Technology (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Part of Genesis MedTech International Pte Ltd., Jianshi Medical Technology (Shanghai) Co., Ltd. is a Chinese company that manufactures and distributes medical devices. The company is based in Shanghai, China. The company was founded in 2019. The CEO is Xin Wang. | Health Technology |
Genesis MedTech International Pte Ltd.
Genesis MedTech International Pte Ltd. Medical SpecialtiesHealth Technology Genesis MedTech International Pte Ltd. is a Singaporean medical device company that focuses on value segment multi-therapy medical device products for emerging markets. It has subsidiaries in Singapore, China, and Japan. The company was founded by a group of professionals and entrepreneurs with medtech experience and is headquartered in Singapore, Singapore. Xin Wang has been the CEO of the company since 2020. | Health Technology |
